205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.23%
Net income growth similar to MRVL's 20.82%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
5.51%
Some D&A expansion while MRVL is negative at -1.55%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
61.18%
Well above MRVL's 34.93% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-25.00%
Negative yoy SBC while MRVL is 3.73%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-262.07%
Negative yoy working capital usage while MRVL is 266.99%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-277.50%
AR is negative yoy while MRVL is 97.36%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-726.09%
Negative yoy inventory while MRVL is 524.78%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-87.25%
Both negative yoy AP, with MRVL at -103.89%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
2910.00%
Growth well above MRVL's 150.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-1166.67%
Both negative yoy, with MRVL at -37.09%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
10.25%
Operating cash flow growth below 50% of MRVL's 347.11%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-23.68%
Negative yoy CapEx while MRVL is 50.85%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Negative yoy acquisition while MRVL stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
12.06%
Purchases growth of 12.06% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-13.74%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-186.67%
We reduce yoy other investing while MRVL is 150.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
No Data
No Data available this quarter, please select a different quarter.
-993.33%
Both yoy lines negative, with MRVL at -76.09%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-52.82%
Both yoy lines negative, with MRVL at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-347.89%
We cut yoy buybacks while MRVL is 2.34%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.